First CRISPR editing trial results assuage safety concerns

Editing bone marrow cells did not cure a patient’s HIV, but researchers are encouraged

Search for this author in:

HIV particles emerging from lymphocytes. Getty Images

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

doi: 10.1038/d41591-019-00019-4


  1. 1.

    Xu L., Wang J., Liu Y., et al. N. Engl. J. Med. doi: 10.1056/NEJMoa1817426 (2019).

  2. 2.

    Allers, K. et al. Blood 117, 2791–2799 (2011).

  3. 3.

    Gupta, R. K., et al. Nature 568, 244–248 (2019).

  4. 4.

    Wu, Y., et al. Nat. Med. 25, 776–783 (2019).

  5. 5.

    Tebas, P., et al. N. Engl. J. Med. 370, 901–910 (2014).

Download references

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.